🇺🇸 FDA
Patent

US 11299482

Salt and crystal form of modified andrographolide compound and preparation method thereof

granted A61PA61P11/00

Quick answer

US patent 11299482 (Salt and crystal form of modified andrographolide compound and preparation method thereof) held by Medshine Discovery Inc. expires Mon Apr 07 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Medshine Discovery Inc.
Grant date
Tue Apr 12 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 07 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61P, A61P11/00